Chat with us, powered by LiveChat

 Speaker Profile

PMWC PIONEER AWARD
Honored for bringing nanopore long-read sequencing into clinical practice, enabling real-time whole-genome analysis (SVs, phasing, methylation) and faster results from sample to report

Ph.D., CEO and Co-Founder, Oxford Nanopore

Biography
CEO and co-founder of Oxford Nanopore Technologies, pioneering real-time, scalable DNARNA sequencing. With a PhD in bioelectronic technology, he led the company from spinout to global player, transforming genomics with portable sequencing devices. Sanghera champions accessible, decentralized sequencing for research, healthcare, and public health worldwide.


Talk
In conversation with Gordon Sanghera
Gordon will chart his journey as CEO of Oxford Nanopore, from early vision and product development, through to scaling operations, navigating challenges, achieving their IPO and onward growth since then. He reflects on the importance of culture, innovation and resilient leadership, and how these strong foundations can help to drive the company forward.


 Session Abstract – PMWC 2026 Silicon Valley

Track 3 - March 5 9.00 A.M.-4.45 P.M.


Track Chair: TBA

PMWC Award Ceremony Honorees
• Mark Daly, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD
• Gordon Sanghera, Oxford Nanopore
• Howard J. Jacob, Abbvie

The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley

Biobanks to Bedside: Cutting VUS in Cancer, Cardio & Rare—What’s Working Now
• Chair: Ben Neale, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD

Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford

DNA to FDA: How Genetic Targets Win Labels & Coverage
• Russ B. Altman, Stanford

Common Diseases in Clinical Cohorts – Not Always What They Seem
• Howard J. Jacob, Abbvie

DNA to FDA: How Genetic Targets Win Labels & Coverage
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B. Altman, Stanford

25+ Years of the Human Genome — What Made It to the Bedside
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by NOV. 6TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required